7549 related articles for article (PubMed ID: 1722705)
1. Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2.
Olive D; Lopez M; Blaise D; Viens P; Stoppa AM; Brandely M; Mawas C; Mannoni P; Maraninchi D
J Immunother (1991); 1991 Dec; 10(6):412-7. PubMed ID: 1722705
[TBL] [Abstract][Full Text] [Related]
2. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.
Archimbaud E; Thomas X; Campos L; Magaud JP; Doré JF; Fiere D
Leukemia; 1992 Apr; 6(4):265-71. PubMed ID: 1375302
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
5. Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity.
Cesano A; Lista P; Bellone G; Geuna M; Brizzi MF; Rossi PR; Pegoraro L; Oberholtzer E; Matera L
Leukemia; 1992 Jun; 6(6):567-73. PubMed ID: 1376379
[TBL] [Abstract][Full Text] [Related]
6. Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2.
Olive D; Chambost H; Sainty D; Stoppa AM; Blaise D; el Marsafy S; Brandely M; Mannoni P; Mawas C; Maraninchi D
Leukemia; 1994 Jul; 8(7):1230-5. PubMed ID: 8035617
[TBL] [Abstract][Full Text] [Related]
7. Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity.
Raspadori D; Lauria F; Ventura MA; Rondelli D; Tura S
Ann Hematol; 1993 Nov; 67(5):213-6. PubMed ID: 7694662
[TBL] [Abstract][Full Text] [Related]
8. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation.
Teunissen MB; Rongen HA; Bos JD
J Immunol; 1994 Apr; 152(7):3400-9. PubMed ID: 7511646
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
Bendall LJ; Kortlepel K; Gottlieb DJ
Leukemia; 1995 Apr; 9(4):677-84. PubMed ID: 7723403
[TBL] [Abstract][Full Text] [Related]
10. Biological response modifiers render tumor cells susceptible to autologous effector mechanisms by influencing adhesion receptors.
Schirren CA; Völpel H; Hoffmann JC; Henning SW; Qiao L; Autschbach F; Dengler TJ; Döhner H; Meuer SC
Leuk Lymphoma; 1993 May; 10(1-2):25-33. PubMed ID: 7690630
[TBL] [Abstract][Full Text] [Related]
11. Immune modulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human hepatocytic cell lines.
Kvale D; Brandtzaeg P
J Hepatol; 1993 Mar; 17(3):347-52. PubMed ID: 7686194
[TBL] [Abstract][Full Text] [Related]
12. The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells.
Tandon N; Makgoba MW; Gahmberg CG; Weetman AP
Clin Immunol Immunopathol; 1992 Jul; 64(1):30-5. PubMed ID: 1376653
[TBL] [Abstract][Full Text] [Related]
13. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
14. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia.
Kimby E; Rincón J; Patarroyo M; Mellstedt H
Leuk Lymphoma; 1994 Apr; 13(3-4):297-306. PubMed ID: 7519509
[TBL] [Abstract][Full Text] [Related]
15. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
Damle NK; Klussman K; Linsley PS; Aruffo A
J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
[TBL] [Abstract][Full Text] [Related]
16. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves' and Hashimoto's diseases.
Zheng RQ; Abney ER; Grubeck-Loebenstein B; Dayan C; Maini RN; Feldmann M
J Autoimmun; 1990 Dec; 3(6):727-36. PubMed ID: 1708262
[TBL] [Abstract][Full Text] [Related]
17. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
[TBL] [Abstract][Full Text] [Related]
18. Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia.
Archimbaud E; Campos L; Vila L; Thomas X
Immunol Lett; 1993 Dec; 39(1):13-5. PubMed ID: 7511562
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC
Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338
[TBL] [Abstract][Full Text] [Related]
20. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM
Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
